EVGOMarch 3, 2026 at 12:00 PM UTCAutomobiles & Components

EVgo Reports Record Revenue Growth but Profitability Remains Uncertain, with 2026 Guidance Highlighting Execution Risks

Read source article

What happened

EVgo announced record fourth-quarter and full-year 2025 results, with Q4 revenue surging 75% year-over-year to $118 million and full-year revenue reaching $384 million, up 50%, driven by strong charging network performance. The company issued 2026 revenue guidance of $410-470 million and Adjusted EBITDA guidance ranging from a loss of $20 million to a profit of $20 million, suggesting a potential transition to breakeven. However, despite this top-line growth, EVgo remains structurally loss-making, with negative Adjusted EBITDA in recent quarters and ongoing cash burn, as highlighted in the DeepValue report. Management's optimistic guidance is tempered by a history of resetting EBITDA expectations, and the wide range reflects underlying uncertainties in cost control and utilization amid competitive and policy headwinds. Critical execution risks persist, including DOE loan drawdowns, covenant compliance, and intensifying competition from Tesla and OEM-backed networks, which could delay or undermine the path to profitability.

Implication

The revenue growth confirms EVgo's network scaling, but the ambiguous Adjusted EBITDA guidance indicates management's uncertainty about achieving breakeven, requiring skepticism given past guidance resets. Dependency on DOE funding and partnerships like GM/Pilot introduces significant risk if milestones are missed or policy support weakens, potentially straining finances. At current valuation levels, the market assumes a smooth profitability transition, yet historical execution issues and sector challenges, such as slower EV adoption, cast doubt on this assumption. Investors must monitor quarterly EBITDA trends, DOE loan utilization, and per-stall throughput to assess whether operational leverage is materializing without equity dilution. Until clear evidence of sustained breakeven EBITDA emerges, the 'WAIT' rating is justified, with more attractive entry points likely around $2.25, aligning with the DeepValue report's risk-reward assessment.

Thesis delta

The strong Q4 results and 2026 guidance show progress toward the base scenario of disciplined capital deployment and near-breakeven EBITDA by late 2026, as outlined in the DeepValue report. However, no material shift in the investment thesis occurs, as the company still needs to demonstrate it can achieve and sustain profitability without external risks impacting funding or operations, maintaining the 'WAIT' call until more conclusive evidence emerges.

Confidence

High